209 related articles for article (PubMed ID: 12391285)
21. Inhibition of cyclooxygenase-2 and activation of peroxisome proliferator-activated receptor-gamma synergistically induces apoptosis and inhibits growth of human breast cancer cells.
Michael MS; Badr MZ; Badawi AF
Int J Mol Med; 2003 Jun; 11(6):733-6. PubMed ID: 12736714
[TBL] [Abstract][Full Text] [Related]
22. Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligands inhibits human lung carcinoma cell growth.
Han S; Roman J
Biochem Biophys Res Commun; 2004 Feb; 314(4):1093-9. PubMed ID: 14751245
[TBL] [Abstract][Full Text] [Related]
23. Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines.
Campbell SE; Stone WL; Whaley SG; Qui M; Krishnan K
BMC Cancer; 2003 Oct; 3():25. PubMed ID: 14521714
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review).
Badawi AF; Badr MZ
Int J Oncol; 2002 Jun; 20(6):1109-22. PubMed ID: 12011987
[TBL] [Abstract][Full Text] [Related]
25. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.
Lim JT; Piazza GA; Han EK; Delohery TM; Li H; Finn TS; Buttyan R; Yamamoto H; Sperl GJ; Brendel K; Gross PH; Pamukcu R; Weinstein IB
Biochem Pharmacol; 1999 Oct; 58(7):1097-107. PubMed ID: 10484067
[TBL] [Abstract][Full Text] [Related]
26. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
28. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
[TBL] [Abstract][Full Text] [Related]
29. 85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells.
Pawliczak R; Han C; Huang XL; Demetris AJ; Shelhamer JH; Wu T
J Biol Chem; 2002 Sep; 277(36):33153-63. PubMed ID: 12077117
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo.
Eli Y; Przedecki F; Levin G; Kariv N; Raz A
Biochem Pharmacol; 2001 Mar; 61(5):565-71. PubMed ID: 11239499
[TBL] [Abstract][Full Text] [Related]
32. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
Moon Y; Bottone FG; McEntee MF; Eling TE
Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405
[TBL] [Abstract][Full Text] [Related]
33. Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition.
Tinsley HN; Gary BD; Thaiparambil J; Li N; Lu W; Li Y; Maxuitenko YY; Keeton AB; Piazza GA
Cancer Prev Res (Phila); 2010 Oct; 3(10):1303-13. PubMed ID: 20876730
[TBL] [Abstract][Full Text] [Related]
34. PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist.
Bishop-Bailey D; Warner TD
FASEB J; 2003 Oct; 17(13):1925-7. PubMed ID: 12897060
[TBL] [Abstract][Full Text] [Related]
35. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
36. The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers.
DuBois RN; Gupta R; Brockman J; Reddy BS; Krakow SL; Lazar MA
Carcinogenesis; 1998 Jan; 19(1):49-53. PubMed ID: 9472692
[TBL] [Abstract][Full Text] [Related]
37. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis.
Bottone FG; Martinez JM; Collins JB; Afshari CA; Eling TE
J Biol Chem; 2003 Jul; 278(28):25790-801. PubMed ID: 12734198
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
39. Both PPARgamma and PPARdelta influence sulindac sulfide-mediated p21WAF1/CIP1 upregulation in a human prostate epithelial cell line.
Jarvis MC; Gray TJ; Palmer CN
Oncogene; 2005 Dec; 24(55):8211-5. PubMed ID: 16091736
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of eicosanoids and NSAIDs as PPARgamma ligands in colorectal carcinoma cells.
Nixon JB; Kamitani H; Baek SJ; Eling TE
Prostaglandins Leukot Essent Fatty Acids; 2003 May; 68(5):323-30. PubMed ID: 12711249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
